Original Research
Published on 08 May 2026
Efficacy and safety of finerenone in chronic kidney disease stages 3–4 in diabetic and non-diabetic patients with an eGFR 20–60 mL/min: a prospective cohort study
in Clinical Research in Nephrology
- 526 views